EcoDrugPlus

Adrenoceptor Alpha 2c

Ensembl ID : ENSPREG00000014061
Gene Symbol: ADRA2C
2 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSPREG00000022648
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSPREG00000019818
Gene Symbol: ADRB2A
1 Cross references
195 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSPREG00000010944
Gene Symbol: LOC103459462
3 Cross references
343 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSPREG00000010966
Gene Symbol: LOC103459461
3 Cross references
345 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSPREG00000006260
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Alpha-1a Adrenergic Receptor

Ensembl ID : ENSPREG00000008600
Gene Symbol: LOC103470566
3 Cross references
202 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSPREG00000012347
Gene Symbol: LOC103470062
3 Cross references
174 Possible Orthologues:

Alpha-2c Adrenergic Receptor-Like

Ensembl ID : ENSPREG00000000530
Gene Symbol: LOC103464341
3 Cross references
160 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSPREG00000016906
Gene Symbol: LOC103473856
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSPREG00000012062
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amylase Alpha 1c

Ensembl ID : ENSPREG00000011238
Gene Symbol: AMY1C
4 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).